Back to search

University of British Columbia

Understanding the impact of senescence on CAR-T cell manufacturing

Abstract

dc:description

Chimeric antigen receptor (CAR)-T cell therapy has proven efficacious in hematological malignancies, with success in CD19-targeted therapy for leukemia/lymphoma and B cell maturation antigen (BCMA)-targeted therapy in multiple myeloma. However, a significant portion of patients still relapse post-therapy. Factors such as T cell exhaustion and T cell memory phenotypes have been thought to contribute, given that they may impact persistence which has been correlated with poor outcomes after CAR-T cell therapy. In this project, we explore whether telomere maintenance plays a role in CAR-T cell persistence, given that shortened telomeres result in a loss of proliferative capacity. During CAR-T cell manufacturing, the T cells undergo a rapid expansion phase, which may lead to telomere shortening. Thus, methods were explored to measure telomerase activity, telomere length, cell cycle progression, senescence-associated 𝛽-galactosidase (SA 𝛽-gal) activity, and various cell surface markers. Through repetitive stimulations, telomerase activity decreased with each round of stimulations, and cells reached a plateau in growth. SA 𝛽-gal increased with each round of stimulation and an increased proportion of cells were observed in G₀/G₁. To address this, an 8-day and 12-day manufacturing process was assessed, to determine if this may better preserve cell phenotype. The 8-day process had an increased proportion of the cells in G₂/M compared to the 12-day manufacture, however had increased levels of SA 𝛽-gal. Lastly, epigenetic age has been explored as a potential predictor of patient outcomes and was assessed in healthy donor samples and patient samples from a CD19-directed CAR-T cell clinical trial. Responders were found to have a lower epigenetic age than non-responders, providing the rationale for further study.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Interdisciplinary Oncology
Grantor dc:publisher
University of British Columbia
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Sankaran, Saambavi Charu
Contributors dc:contributor
  • Hay, Kevin A.
  • Lansdorp, Peter M

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/89265

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Sankaran, Saambavi Charu. Understanding the impact of senescence on CAR-T cell manufacturing. master's thesis, University of British Columbia, 2024. http://hdl.handle.net/2429/89265